Libtayo Prior Authorization Request Form
This document is a payer-specific prior authorization (PA) request form to collect patient, prescriber, diagnosis, and clinical information for coverage review of Libtayo (cemiplimab-rwlc). It guides submission methods, urgency designation, administration/dispensing location, and detailed diagnosis-specific clinical questions to support PA decisions.
No material clinical/coverage changes — brief indicates this is an informational PA form without material change.
Policy snapshot & scope
This is a payer-specific prior authorization (PA) request form for Libtayo (cemiplimab-rwlc) that collects patient, prescriber, diagnosis, and clinical information to support coverage review. The form can be submitted by fax to (855) 840-1678 or online via covermymeds.com or SureScripts in the EHR, and urgent requests require a phone call to (800) 882-4462 to expedite. Requesters must indicate Urgency: Standard or Urgent, specify where the medication will be obtained or administered (Onco360, prescriber office stock billed on medical claim, home health/home infusion vendor, or other) and provide facility/dispensing details (including Tax ID). The form gathers asterisk-marked required identifiers and detailed, diagnosis-specific clinical questions to support the payer's medical necessity determination.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.